trial
as of 2026-07-01An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.
NCTId NCT00391261
at a glance
Phase 4 · Completed
Enrollment 11 (actual)
Sponsored by Cambridge Health Alliance
Primary completion 2007-10
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
11 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Single Group
Masking
None
Start
2006-07
Primary completion
2007-10
Eligibility
ALL · 10 Years · 18 Years
Interventions & indications
Sponsors
Cambridge Health AllianceLead Sponsor
American Psychiatric AssociationCollaborator
Investigators
1
Jean A Frazier, MDPrincipal Investigator
Sites
1 total
Medford, United States
Facts & assertions
4 sourced
Enrollment
11
Phase
PHASE4
Primary Completion Date
2007-10
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
company
collaborator
indication
investigator
person